Startup Pitch: Clinical Decision Support Consortium Sustainability Model
|
If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL). |
Abstract
The Clinical Decision Support (CDS) Consortium is a Harvard-based federally-funded multi-institutional academic-industrial research collaborative spanning several countries. The CDS Consortium is focused on advancing the adoption and effective use of clinical decision support in health care. Current partners include a wide variety of academic and community provider institutions, leading Health Information Technology (HIT) companies, Electronic Health Record (EHR) companies, and knowledge vendors. (See http://www.partners.org/cird/cdsc/). The CDS Consortium develops solutions for sharing CDS knowledge as human-readable artifacts, and as web services integrated with multiple vendor EHR systems – across state borders while respecting HIPAA regulations. We are currently live with a cloud-based CDS service integrated into the Regenstrief Medical Record System and Partners HealthCare Longitudinal Medical Record. In the coming year, our CDS services will go live in NextGen and GE Electronic Medical Record sites.
The CDS Consortium delivers the following key products, services, and resources to enable cost-effective knowledge management and CDS: a Knowledge Management Portal for knowledge sharing and collaboration, cloud-based CDS services, an in vivo research and development lab, and education and consulting services. We identify the following groups as our potential customers: healthcare providers, payers, EHR vendors, and content vendors. We also find other stakeholders in the HIT community who have much to gain from the success of this consortium, such as HIT platform vendors, guideline developers, medical specialty societies, and the governmental entities seeking success with HIT adoption and meaningful use. The CDS Consortium offerings are unique because they provide innovative approaches to CDS development, adoption and deployment in a nascent HIT market, and may be used across disparate technical platforms and architectures as well as diverse care settings, at scale.
The CDS Consortium provides a valuable pre-competitive environment for advancing the state of the art in clinical decision support, and is in its final year of federal funding. It continues to attract the attention of various stakeholders, now including 7 academic institutions, 5 provider organizations, and 9 commercial entities. The CDS Consortium developed a novel business model for sustaining this effort post-federal funding based on knowledge licensing fees, transaction fees, and ongoing R&D revenue. The CDS Consortium goal is to provide high value to all member organizations in achieving the effective delivery and use of cutting-edge clinical decision support.
The CDS Consortium delivers the following key products, services, and resources to enable cost-effective knowledge management and CDS: a Knowledge Management Portal for knowledge sharing and collaboration, cloud-based CDS services, an in vivo research and development lab, and education and consulting services. We identify the following groups as our potential customers: healthcare providers, payers, EHR vendors, and content vendors. We also find other stakeholders in the HIT community who have much to gain from the success of this consortium, such as HIT platform vendors, guideline developers, medical specialty societies, and the governmental entities seeking success with HIT adoption and meaningful use. The CDS Consortium offerings are unique because they provide innovative approaches to CDS development, adoption and deployment in a nascent HIT market, and may be used across disparate technical platforms and architectures as well as diverse care settings, at scale.
The CDS Consortium provides a valuable pre-competitive environment for advancing the state of the art in clinical decision support, and is in its final year of federal funding. It continues to attract the attention of various stakeholders, now including 7 academic institutions, 5 provider organizations, and 9 commercial entities. The CDS Consortium developed a novel business model for sustaining this effort post-federal funding based on knowledge licensing fees, transaction fees, and ongoing R&D revenue. The CDS Consortium goal is to provide high value to all member organizations in achieving the effective delivery and use of cutting-edge clinical decision support.
Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.
This work is licensed under a Creative Commons Attribution 3.0 License.